Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum.
Ueda A, Hosokawa A, Ogawa K, Yoshita H, Mihara H, Ando T, Kajiura S, Fujinami H, Nishikawa J, Minemura M, Terada M, Kobayashi T, Horikawa N, Yabushita K, Note M, Sugiyama T. Ueda A, et al. Among authors: horikawa n. Anticancer Res. 2013 Nov;33(11):5107-11. Anticancer Res. 2013. PMID: 24222156
Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective study.
Ogawa K, Hosokawa A, Ueda A, Saito S, Mihara H, Ando T, Kajiura S, Terada M, Tsukioka Y, Horikawa N, Kobayashi T, Note M, Sawasaki K, Fukuoka J, Sugiyama T. Ogawa K, et al. Among authors: horikawa n. Gastroenterol Res Pract. 2012;2012:640401. doi: 10.1155/2012/640401. Epub 2012 Feb 15. Gastroenterol Res Pract. 2012. PMID: 22474446 Free PMC article.
Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis.
Ando T, Ueda A, Ogawa K, Motoo I, Kajiura S, Nakajima T, Hirano K, Okumura T, Tsukada K, Hara T, Suzuki N, Nakada N, Horikawa N, Fujii T, Yasuda I. Ando T, et al. Among authors: horikawa n. In Vivo. 2021 Jan-Feb;35(1):475-482. doi: 10.21873/invivo.12281. In Vivo. 2021. PMID: 33402499 Free PMC article.
153 results